151751-Najiba-Chargi

390 CHAPTER 19 Table 2. (Continued) Total N=150 Sarcopenic N=21 Non Sarcopenic N=129 χ 2 p-value 20-24.9 9 6 0 0 9 7 25-29.9 64 43 10 48 54 42 ≥ 30 24 16 1 4 23 18 Smoker (n, %) No 26 17 4 19 22 17 0.05 0.98 Former 73 49 7 33 44 34 Current 51 34 10 48 63 49 Alcohol use (n, %) No 29 18 4 19 25 19 0.71 0.70 Yes 101 62 13 62 88 68 Former 20 12 4 19 16 13 ACE-27 score (n, %) Non 49 33 0 0 49 38 12.2 0.007* Mild 54 36 12 57 42 32 Moderate 29 19 6 29 23 18 Severe 18 12 3 14 15 12 Localization (n, %) Oral cavity 32 21 5 24 27 21 4.72 0.79 Nasal cavity 6 4 0 0 6 5 Nasopharynx 6 4 0 0 6 5 Oropharynx 37 25 4 19 33 25 Hypopharynx 11 7 1 5 10 8 Larynx 29 19 5 24 24 19 Salivary glands 17 11 4 19 13 10 Skin 2 1 0 0 2 1 unknown primary 10 7 2 9 8 6 Type of tumor (n, %) Primary 143 95 21 100 122 94 1.20 0.55 Recurrent 1 1 0 0 1 1 Second primary 6 4 0 0 6 5 Histology (n, %) Squamous 119 79 17 81 102 80 0.15 0.93 Adenocarcinoma 18 12 2 9 16 12 Other 13 9 2 10 11 8 TNM Stage (n, %)